BPC-157 vs PT-141: side-by-side comparison
BPC 157 · Body Protection Compound-157 · Pentadecapeptide
A peptide derived from a protein found in stomach acid with profound tissue-healing properties. Used for healing tendons, ligaments, gut inflammation, and various injuries.
Bremelanotide · Vyleesi
A melanocortin agonist used for sexual dysfunction. FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women; also used off-label by some men for sexual dysfunction, though it carries no FDA approval or official dosing guidance for that use.
1 / 10 natty scale / 1
Same lane
Both sit in the same class and are run for health. This is a like-for-like comparison: read the gaps as real trade-offs.
The tape
Core ratings
The same three rulers every entry on the site is scored with, read head to head.
Natty scale
1 natural · 10 heavy
Effectiveness
Documented effect · of 5Δ1
Side-effect severity
Documented burden · of 5Δ1.5
Cost side
Body-load fingerprint
Where each one actually lands its strain, on the calculator's thirteen channels. Tap a row for what it means and which labs track it.
Cardiometabolic
Organ strain
Systemic
Injection & site care
Bars show strain at each one's typical protocol, not your dose. ≈ marks values inferred from side-effect data or category rather than hand-graded. For your numbers, run the calculator.
Logistics
The vitals
Benefit side
What each is for
Shared goals carry both dots; a goal with one dot belongs to that side alone.
Run for
Documented upside
- Accelerated tendon and ligament healing
- Gut repair and protection
- Enhanced wound healing
- Anti-inflammatory effects
- Neuroprotective properties
Run for
Documented upside
- Increased sexual desire
- Works on desire, not just function
- Clinically validated (FDA-approved) efficacy in women; also used off-label by men
- FDA-approved
- May complement PDE5 inhibitors via a different (central) mechanism
The downsides
Side effects, aligned
Each entry's documented side effects, sorted onto the same body systems so the gaps and the overlaps are visible. Tap any effect for the detail.
None documented
None documented
The exit
Hormonal fallout & recovery
What each does to your own hormone axis while on, and what leaving it costs.
BPC-157
Does not affect hormones. No PCT required.
PT-141
Not hormonal in the traditional sense. No PCT required.
Read-out
How they separate
- 01
Enhancement
They land at almost the same point on the natty scale (1/10 vs 1/10): a similar distance beyond natural.
- 02
Side-effect bill
PT-141's documented side-effect severity is heavier (2.5/5 vs 1/5). The body-load fingerprint above shows where that weight actually lands.
- 03
Body load
The widest gap at typical protocols is heart structure (PT-141 4/10 vs 0/10), then blood pressure (PT-141 4/10 vs 0/10).
- 04
Coming off
Neither requires PCT: both leave the natural testosterone axis running.
- 05
Logistics
typical runs are 4-8 weeks vs 8-26 weeks.
- 06
Tested athletes
BPC-157 is WADA-prohibited; PT-141 is not on the prohibited list.
Generated from each entry's data file. Descriptive, not a recommendation; nothing here is medical advice.